The University of Chicago Header Logo

Connection

Fredric L. Coe to Calcium Phosphates

Back to Details
This is a "connection" page, showing publications Fredric L. Coe has written about Calcium Phosphates.
Fredric L. Coe
Connection Strength
3.451
Calcium Phosphates
  1. Evidence for disordered acid-base handling in calcium stone-forming patients. Am J Physiol Renal Physiol. 2020 02 01; 318(2):F363-F374.
    View in: PubMed
    Score: 0.666
  2. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48.
    View in: PubMed
    Score: 0.445
  3. Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2083-92.
    View in: PubMed
    Score: 0.374
  4. Proportional reduction of urine supersaturation during nephrolithiasis treatment. J Urol. 2001 Oct; 166(4):1247-51.
    View in: PubMed
    Score: 0.189
  5. Divergence between stone composition and urine supersaturation: clinical and laboratory implications. J Urol. 1999 Apr; 161(4):1077-81.
    View in: PubMed
    Score: 0.159
  6. Papillary Ductal Plugging is a Mechanism for Early Stone Retention in Brushite Stone Disease. J Urol. 2018 01; 199(1):186-192.
    View in: PubMed
    Score: 0.142
  7. Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol. 1996 Apr; 270(4 Pt 2):F604-13.
    View in: PubMed
    Score: 0.129
  8. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease. J Urol. 2015 Nov; 194(5):1308-12.
    View in: PubMed
    Score: 0.122
  9. Mechanism by which shock wave lithotripsy can promote formation of human calcium phosphate stones. Am J Physiol Renal Physiol. 2015 Apr 15; 308(8):F938-49.
    View in: PubMed
    Score: 0.119
  10. Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012 Jun; 81(11):1140-8.
    View in: PubMed
    Score: 0.097
  11. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63.
    View in: PubMed
    Score: 0.088
  12. Evidence for durable kidney stone prevention over several decades. BJU Int. 2009 May; 103(9):1238-46.
    View in: PubMed
    Score: 0.078
  13. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6.
    View in: PubMed
    Score: 0.076
  14. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008 Jul; 74(2):223-9.
    View in: PubMed
    Score: 0.075
  15. Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608.
    View in: PubMed
    Score: 0.062
  16. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91.
    View in: PubMed
    Score: 0.060
  17. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85.
    View in: PubMed
    Score: 0.058
  18. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65.
    View in: PubMed
    Score: 0.052
  19. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol. 2002 Jun; 167(6):2372-6.
    View in: PubMed
    Score: 0.050
  20. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2002 Mar; 61(3):975-87.
    View in: PubMed
    Score: 0.049
  21. Differences in urine volume and supersaturation in 2 physician networks. J Urol. 2001 Aug; 166(2):423-8.
    View in: PubMed
    Score: 0.047
  22. In Vivo Renal Tubule pH in Stone-Forming Human Kidneys. J Endourol. 2020 02; 34(2):203-208.
    View in: PubMed
    Score: 0.042
  23. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int. 1999 Oct; 56(4):1505-16.
    View in: PubMed
    Score: 0.041
  24. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1998 Jun; 159(6):1821-5.
    View in: PubMed
    Score: 0.038
  25. Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int. 1997 Dec; 52(6):1602-8.
    View in: PubMed
    Score: 0.036
  26. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int. 1997 Mar; 51(3):640-5.
    View in: PubMed
    Score: 0.034
  27. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997 Mar; 51(3):894-900.
    View in: PubMed
    Score: 0.034
  28. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int. 1994 Jan; 45(1):58-65.
    View in: PubMed
    Score: 0.028
  29. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol. 2009 Oct; 297(4):F1017-23.
    View in: PubMed
    Score: 0.020
  30. Pathophysiology of kidney stones and strategies for treatment. Hosp Pract (Off Ed). 1988 Mar 15; 23(3):185-9, 193-5, 199-200 passim.
    View in: PubMed
    Score: 0.018
  31. Insights on the pathology of kidney stone formation. Urol Res. 2005 Nov; 33(5):383-9.
    View in: PubMed
    Score: 0.015
  32. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int. 1999 Feb; 55(2):602-12.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.